Additionally, two studies demonstrated the amelioration of pulmonary fibrosis and improved lung function in response to global HDAC inhibition by SAHA in bleomycin-treated C57Bl/6 mice in vivo [164,167]. Here, HDAC9 is linked to pulmonary fibrosis.